(Q42477154)

1 November 2017

title

Expression of vascular endothelial growth factor receptors in human prostate cancer (English)

1 reference

1 November 2017

0 references

1 reference

Ferrer FA

1 reference

1 November 2017

Miller LJ

1 reference

1 November 2017

Lindquist R

1 reference

1 November 2017

Kowalczyk P

1 reference

1 November 2017

Laudone VP

1 reference

1 November 2017

Albertsen PC

1 reference

1 November 2017

Kreutzer DL

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 September 1999

1 reference

1 November 2017

1 reference

inferred from page(s)

published in

Urology

1 reference

1 November 2017

1 reference

1 November 2017

1 reference

1 November 2017

page(s)

567-572

1 reference

Comparison of microscopic vascularity in benign and malignant prostate tissue

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900156-9

7 January 2021

What, if anything, is an angiogenic factor?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900156-9

7 January 2021

Regulation of VEGF/VPF expression in tumor cells: consequences for tumor growth and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900156-9

7 January 2021

Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900156-9

7 January 2021

Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900156-9

7 January 2021

Biological properties of VEGF/VPF receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900156-9

7 January 2021

Tumor angiogenesis: therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900156-9

7 January 2021

Biological activity and phosphorylation sites of the bacterially expressed cytosolic domain of the KDR VEGF-receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900156-9

7 January 2021

Interaction of the Flt-1 tyrosine kinase receptor with the p85 subunit of phosphatidylinositol 3-kinase. Mapping of a novel site involved in binding

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900156-9

7 January 2021

Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900156-9

7 January 2021

Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900156-9

7 January 2021

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900156-9

7 January 2021

Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900156-9

7 January 2021

10.1016/S0090-4295(99)00156-9

Identifiers

DOI

1 reference

1 November 2017

1 reference